44 BIOGAIA SUSTAINABILITY REPORT 2021 GRI Standard Disclosure Page number(s) Comment GRI 3: Material Topics 2021 3-1 Process to determine material topics p. 40 3-2 List of material topics p. 40 3-3 Management of material topics – Well-documented products & transparent product information – Product quality and product safety – Material use, raw materials – Anti-corruption and anti-bribery – Environmental impact of operations – Responsible suppliers – Responsible partners – Responsible research – Employee well-being – Diversity and equal opportunities – Training and development – Safety in production p. 12 p. 15 p. 16 p. 20 p. 21 p. 26 p. 27 p. 27 p. 30 p. 32 p. 33 p. 35 Related indicators: BSD1, BSD 2 BSD 3 BSD 4, BSD 5, BSD 8, 301-1, 301-2 205-2, 205-3 305-1, 305-2, 305-3, 305-4 414-1, BSD 6 BSD 7 No quantitative indicator 401-1, 2-7 401-3, 405-1 404-3 403-9 GRI 200: Economic disclosures 205-2 Communication and training on anti-corruption policies and procedures p. 20 Not broken down by region, with the exception that employees in Japan have not taken part in anti-corruption training in 2021. Not broken down by employment category. 205-3 Confirmed incidents of corruption and actions taken p. 20 GRI 300: Environmental disclosures 301-1 Materials used by weight or volume p. 17 301-2 Recycled input materials used p. 17 305-1 Direct (Scope 1) GHG emissions p. 23 Excluding biogenic emissions 305-2 Energy indirect (Scope 2) GHG emissions p. 23 Excluding biogenic emissions 305-3 Other indirect (Scope 3) GHG emissions p. 23 Excluding biogenic emissions 305-4 GHG emissions intensity p. 17 & 23 GRI 400: Social disclosures 401-1 New employee hires and employee turnover p. 31 Not broken down by region 401-3 Parental leave p. 34 403-9 Work-related injuries p. 35 Total number of hours worked is not reported 404-3 Percentage of employees receiving regular performance and career development reviews p. 32 405-1 Diversity of governance bodies and employees p. 34 414-1 New suppliers that were screened using social criteria p. 26 BioGaia specific disclosures (BSD) BSD 1 Published clinical studies per strain combination p. 12 BSD 2 Criteria for probiotics and BioGaia’s assessment of level of compliance p. 13 BSD 3 Number of recalls p. 15 BSD 4 Emissions from ingredients p. 17 BSD 5 Emissions from packaging materials p. 17 BSD 6 Percentage of suppliers that have signed the Supplier Code of Conduct p. 26 Includes contract manufacturers, culture producers and analytical services BSD 7 Percentage of partners that have signed the partner Code of Conduct p. 27 BSD 8 Phase-out of palm oil in BioGaia’s products p. 17 GRI index, cont. CONTENTS
RkJQdWJsaXNoZXIy NjAyMDA=